Can You Be on Semaglutide While Pregnant? What the Evidence Says

Why semaglutide is not used in pregnancy, and what 'not recommended' actually means

The phrase 'not recommended' in a medicines context is not a gentle suggestion. For semaglutide, it reflects a specific absence of safety data in pregnant women combined with animal reproductive toxicity findings that regulators take seriously. Rodent studies at doses used to establish the licensed range showed developmental abnormalities; while animal data does not translate directly to human risk, it is enough for the MHRA and prescribers to consider any exposure during pregnancy unacceptable until evidence proves otherwise.

No large controlled trial has been run in pregnant women, ethically, it could not be. What exists instead is a precautionary framework. The NHS medicines information on semaglutide is clear: tell your doctor straight away if you become pregnant, and stop taking it. That instruction applies whether you are on the weekly injection or, as of summer 2026, the new oral tablet form that the MHRA approved for weight management in June 2026.

Breastfeeding carries the same caution. It is not known whether semaglutide passes into breast milk in meaningful quantities. Given that uncertainty, prescribers do not consider it appropriate to continue treatment while nursing. The same logic applies: insufficient data plus a plausible risk pathway means the precautionary answer is to stop.

What to do if you are already taking semaglutide and find out you are pregnant

Stop the injection. Then contact your GP or midwife the same day if you can, not because this is an emergency, but because your care team needs to know promptly to update your notes and arrange any monitoring appropriate to early pregnancy.

One practical check worth doing right now if you are unsure about your pregnancy status: most pharmacies sell tests that give a reliable result within a minute. If there is any doubt, check before your next scheduled dose rather than after it. Our page on whether you can take semaglutide while pregnant explains why timing matters, including how the drug's half-life means a single additional dose extends your exposure by roughly a week.

The overlap between Wegovy and pregnancy is a situation our prescribers take seriously. At nume, any patient who discloses pregnancy during a repeat consultation is advised to discontinue immediately, and we follow NHS England's guidance on notifying the GP. A semaglutide prescription is not something that continues across a positive pregnancy test.

If you were taking semaglutide for a weight-related condition that genuinely needs managing during pregnancy (type 2 diabetes is a separate question handled by your diabetes team) your GP or obstetrician will discuss alternatives appropriate for antenatal care. Weight management injections are not part of that picture.

Planning a pregnancy while on semaglutide: the wash-out question

If pregnancy is planned rather than a surprise, the question shifts to timing. The MHRA advises a wash-out period before trying to conceive, though the precise duration is a clinical judgement your prescriber makes based on your situation. Our dedicated page on using Wegovy while pregnant covers why guidance often suggests a longer gap to be cautious, rather than simply relying on the drug's half-life of approximately one week; this is a conversation for your GP or a specialist, not a figure to act on independently.

The NHS England guidance on weight management injections addresses contraception and conception planning explicitly. Women of childbearing age using these medicines are advised to use effective contraception throughout treatment. If oral contraceptives are your usual method, tirzepatide (Mounjaro) specifically requires adding a non-oral backup for the first four weeks of treatment and after each dose increase, semaglutide does not carry the same pill-absorption warning, but any queries about your specific contraceptive method are worth raising with your prescriber or GP.

For more on how alcohol interacts with semaglutide treatment more broadly, our page on drinking while on semaglutide covers the relevant guidance. And if you have other health conditions alongside a planned pregnancy, our prescribers can discuss what a safe pause in treatment looks like for you.

Resuming semaglutide after pregnancy or breastfeeding

Semaglutide for weight management can be reconsidered once you are no longer pregnant and have stopped breastfeeding, subject to a fresh clinical assessment. Postpartum weight management is a real clinical priority for many women, and the medicines available have expanded significantly. Wegovy remains a licensed option; the oral tablet form approved in June 2026 offers an alternative for those who prefer not to inject.

A full overview of Wegovy in the UK sets out current eligibility, the titration schedule, and what a private consultation involves. If you want to explore whether treatment is right for you after your pregnancy, the right starting point is a clinical conversation, not a price comparison or a social-media recommendation. You can check your eligibility through a free consultation with one of our GPhC-registered prescribers, who reviews every case personally. No algorithm, no automated approval. A real clinician reads your answers and decides.

For context on what private treatment costs and what is included in a single transparent price, our Wegovy price comparison page sets that out plainly.